# Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

> **NCT03760042** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Within-Subject Active vs Placebo Topical Applications
- **DRUG:** Within-Subject Active vs. Placebo Topical Applications

## Key facts

- **NCT ID:** NCT03760042
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-14
- **Primary completion:** 2019-04-15
- **Final completion:** 2019-04-15
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2019-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760042, "Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03760042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*